Orasis Pharmaceuticals

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Total raised

€25M

€25,373,550

Funding rounds

Investors

distinct backers

Active since

2020-09

latest 2020-09

Funding by year

EUR raised per year

High confidence

Raise-next likelihood11

base rate 30% for Other

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2020-09-10	Other	€25M	Bluestem Capital,Visionary Venture Fund	View deal →

same sector or country